Release Study Lacks Funding

WASHINGTON-The National Research Council wants to lend an in-dependent voice to the current stalemate on the release into the environment of genetically engineered organisms-but it lacks the cash. Its Board on Basic Biology concluded a two-day meeting last month with a resolution stressing "the scientific and economic urgency" of conducting such a study that would seek a scientific consensus on definitions and on classifications of risk. Last year four federal agencies rejected separate requests

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WASHINGTON-The National Research Council wants to lend an in-dependent voice to the current stalemate on the release into the environment of genetically engineered organisms-but it lacks the cash. Its Board on Basic Biology concluded a two-day meeting last month with a resolution stressing "the scientific and economic urgency" of conducting such a study that would seek a scientific consensus on definitions and on classifications of risk.

Last year four federal agencies rejected separate requests to finance all or part of the $585,000 needed. Project Director Bill Walsh said the Board may sponsor a workshop or conference on the subject if it cannot conduct the larger study.

The Office of Technology Assessment is working on a similar report due out next year.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies